OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL)

CUSIP: 67576A100

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
214,467,875
Total 13F shares
133,836,935
Share change
-6,380,907
Total reported value
$1,142,923,387
Put/Call ratio
48%
Price per share
$8.54
Number of holders
177
Value change
-$55,464,898
Number of buys
84
Number of sells
53

Quarterly Holders Quick Answers

What is CUSIP 67576A100?
CUSIP 67576A100 identifies OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) as of Q4 2024

As of 31 Dec 2024, OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) was held by 177 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 133,836,935 shares. The largest 10 holders included Summer Road LLC, Deep Track Capital, LP, VR Adviser, LLC, BlackRock, Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, TCG Crossover Management, LLC, CITADEL ADVISORS LLC, Opaleye Management Inc., and ADAGE CAPITAL PARTNERS GP, L.L.C.. This page lists 177 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.